Get the latest market trends in your inbox

Stay on top of the latest market trends and economic insights with the Axios Markets newsletter. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Minneapolis-St. Paul

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa-St. Petersburg news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa-St. Petersburg

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Photo: Patrick Semansky/AFP via Getty Images

President Trump told reporters on Air Force One Thursday night that he was considering nominating Rep. Doug Collins (R-Ga.) to be his next director of national intelligence, but Collins rebuffed that offer during an appearance on Fox Business' "Mornings with Maria" on Friday.

The state of play: Trump previously hinted he would intervene in the Senate race between Collins and Sen. Kelly Loeffler (R-Ga.). The heated primary race between Collins and Loeffler has raised concerns among Republicans that Democrats could potentially win the special election for the Senate seat, the Atlanta Journal-Constitution writes.

  • The primary challenge from Collins, a top defender of Trump, has "sparked an intraparty Republican brawl."
  • Wealthy business executive Loeffler was appointed to the Senate by Georgia Gov. Brian Kemp over Trump's objections when former Sen. Johnny Isakson retired.

Watch the video:

What he's saying: Collins said the position "is not a job of interest to me at this time. It's not one that I would accept, because I'm running a Senate race down here in Georgia."

The big picture: Trump is currently facing blowback for his appointment of Ric Grenell, a Trump loyalist and the ambassador to Germany, as acting DNI — despite the fact that he has never held a national security position in the past.

  • James Clapper, the longest-serving DNI from 2010 to 2017, told Axios' Dave Lawler that it's "very worrisome installing a partisan with no real intelligence experience in this position."
  • "I spent my life in intelligence, and found the DNI job the hardest thing I've ever tried to do. I can't imagine taking it on, and learning the ABC's of intelligence on an on-the-job basis," he added.

Worth noting, via Axios' Alayna Treene: Trump did not discuss nominating Collins for the DNI position before telling reporters Thursday night, sources familiar with the discussions said.

Go deeper: Rep. Doug Collins confirms Georgia Senate run, triggering GOP battle

Go deeper

3 hours ago - Health

Food banks feel the strain without holiday volunteers

People wait in line at Food Bank Community Kitchen on Nov. 25 in New York City. Photo: Michael Loccisano/Getty Images for Food Bank For New York City

America's food banks are sounding the alarm during this unprecedented holiday season.

The big picture: Soup kitchens and charities, usually brimming with holiday volunteers, are getting far less help.

5 hours ago - Health

AstraZeneca CEO: "We need to do an additional study" on COVID vaccine

Photo: Pavlo Gonchar/SOPA Images/LightRocket via Getty Images

AstraZeneca CEO Pascal Soriot said on Thursday the company is likely to start a new global trial to measure how effective its coronavirus vaccine is, Bloomberg reports.

Why it matters: Following Phase 3 trials, Oxford and AstraZeneca said their vaccine was 90% effective in people who got a half dose followed by a full dose, and 62% effective in people who got two full doses.

Updated 7 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Health: Coronavirus cases rose 10% in the week before Thanksgiving.
  2. Politics: Supreme Court backs religious groups on New York coronavirus restrictions.
  3. World: Expert says COVID vaccine likely won't be available in Africa until Q2 of 2021 — Europeans extend lockdowns.
  4. Economy: The winners and losers of the COVID holiday season.
  5. Education: National standardized tests delayed until 2022.